Reuters examines China's involvement in fighting Malaria in Africa

NewsGuard 100/100 Score

Chinese scientists have been working on enhancing "the rare sweet wormwood shrub, from which artemisinin - the best drug to fight malaria - is derived" in an effort to fight malaria "not on its own soil, where the deadly disease has been sharply pruned back, but in Africa, where it still kills one child every 30 seconds," Reuters reports. According to the news service, "China pledged to help Africa fight malaria at the triennial Forum on China and Africa Cooperation (FOCAC) in 2006 and has since set up 30 anti-malaria and prevention units. The next FOCAC meeting is in Egypt on Nov. 8-9."

Joseph Cheng, a professor at City University in Hong Kong, said China's influence could be expanded by its efforts to eradicate malaria in developing countries. "China is exploring cost effective ways to help the Third World and is interested in making distinct contributions," he said. 

"Tanzania, Kenya and Nigeria have begun farming hybrids of the sweet wormwood shrub with Chinese and Vietnamese ancestry, said Li Guoqiao at the Tropical Medicine Institute. ... Asked if China would export the high-yielding Artemisia annua to Africa, Li said: 'We want to grow them in China and whatever we export depends on bilateral relationships,'" Reuters writes. 

The article includes information about China's "mass drug administration" exercise on the "island of Moheli, which belongs to the Comoros group of islands at the northern mouth of the Mozambique Channel." Reuters writes, "The results were startling. While the parasite carrier rate in Moheli ranged from 5 to 94 percent from village to village before the exercise, that fell to 1 percent or less from January 2008 and has stayed around that figure since" (Lyn, 11/5). 


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO recommends R21/Matrix-M vaccine for malaria prevention in children